Litcius/Paper detail

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo, Jennifer A. Fulcher, David Goodman‐Meza, Julie Elliott, Christian Hofmann, Mary Ann Hausner, Kathie G. Ferbas, Nicole H. Tobin, Grace M. Aldrovandi, Otto O. Yang

2020New England Journal of Medicine1,157 citationsDOIOpen Access PDF

Abstract

Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyVirology2019-20 coronavirus outbreakSpike ProteinBetacoronavirusMedicineImmunologyBiologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 | Litcius